• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于严重急性呼吸综合征冠状病毒2(SARS-CoV-2)奥密克戎变异株突变图谱的见解。

Insights on the mutational landscape of the SARS-CoV-2 Omicron variant.

作者信息

Miller Nathaniel L, Clark Thomas, Raman Rahul, Sasisekharan Ram

机构信息

Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.

Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.

出版信息

bioRxiv. 2021 Dec 10:2021.12.06.471499. doi: 10.1101/2021.12.06.471499.

DOI:10.1101/2021.12.06.471499
PMID:34909771
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8669838/
Abstract

The SARS-COV2 Omicron variant has sparked global concern due to the possibility of enhanced transmissibility and escape from vaccines and therapeutics. In this study, we describe the mutational landscape of the Omicron variant using amino acid interaction (AAI) networks. AAI network analysis is particularly well suited for interrogating the impact of constellations of mutations as occur on Omicron that may function in an epistatic manner. Our analyses suggest that as compared to previous variants of concern, the Omicron variant has increased antibody escape due to mutations in class 3 and 4 antibody epitopes as well as increased escape due to accumulated mutations in class 1 antibody epitopes. We note certain RBD mutations that might further enhance Omicron's escape, and in particular advise careful surveillance of two subclades bearing R346S/K mutations with relevance for certain therapeutic antibodies. Further, AAI network analysis suggests that the function of certain therapeutic monoclonal antibodies may be disrupted by Omicron mutations as a result of the cumulative indirect perturbations to the epitope surface properties, despite point-mutation analyses suggesting these antibodies are tolerant of the set of Omicron mutations in isolation. Finally, for several Omicron mutations that do not appear to contribute meaningfully to antibody escape, we find evidence for a plausible role in enhanced transmissibility via disruption of RBD-down conformational stability at the RBD-RBD interface.

摘要

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)奥密克戎变异株因其可能增强的传播性以及对疫苗和治疗方法的逃逸能力而引发了全球关注。在本研究中,我们使用氨基酸相互作用(AAI)网络描述了奥密克戎变异株的突变图谱。AAI网络分析特别适合于探究奥密克戎变异株上可能以上位性方式起作用的突变组合的影响。我们的分析表明,与先前令人关注的变异株相比,奥密克戎变异株由于3类和4类抗体表位的突变而增加了抗体逃逸,同时也由于1类抗体表位中积累的突变而增加了逃逸。我们注意到某些受体结合域(RBD)突变可能会进一步增强奥密克戎的逃逸能力,尤其建议对携带R346S/K突变且与某些治疗性抗体相关的两个亚分支进行密切监测。此外,AAI网络分析表明,尽管点突变分析表明某些治疗性单克隆抗体单独对奥密克戎变异株的一组突变具有耐受性,但由于表位表面性质的累积间接扰动,奥密克戎变异株的突变可能会破坏这些治疗性单克隆抗体的功能。最后,对于一些似乎对抗体逃逸没有显著贡献的奥密克戎变异株突变,我们发现有证据表明它们可能通过破坏RBD-RBD界面处RBD向下的构象稳定性在增强传播性方面发挥合理作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8a0/8686043/66b889beb9b1/nihpp-2021.12.06.471499v2-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8a0/8686043/4ff2f6c8ed41/nihpp-2021.12.06.471499v2-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8a0/8686043/e53bce3be159/nihpp-2021.12.06.471499v2-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8a0/8686043/66b889beb9b1/nihpp-2021.12.06.471499v2-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8a0/8686043/4ff2f6c8ed41/nihpp-2021.12.06.471499v2-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8a0/8686043/e53bce3be159/nihpp-2021.12.06.471499v2-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8a0/8686043/66b889beb9b1/nihpp-2021.12.06.471499v2-f0003.jpg

相似文献

1
Insights on the mutational landscape of the SARS-CoV-2 Omicron variant.关于严重急性呼吸综合征冠状病毒2(SARS-CoV-2)奥密克戎变异株突变图谱的见解。
bioRxiv. 2021 Dec 10:2021.12.06.471499. doi: 10.1101/2021.12.06.471499.
2
Insights on the mutational landscape of the SARS-CoV-2 Omicron variant receptor-binding domain.关于 SARS-CoV-2 奥密克戎变异株受体结合域突变特征的研究进展。
Cell Rep Med. 2022 Jan 24;3(2):100527. doi: 10.1016/j.xcrm.2022.100527. eCollection 2022 Feb 15.
3
Epistasis at the SARS-CoV-2 RBD Interface and the Propitiously Boring Implications for Vaccine Escape.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)受体结合域(RBD)界面处的上位性及其对疫苗逃逸的平淡无奇的影响
bioRxiv. 2021 Dec 22:2021.08.30.458225. doi: 10.1101/2021.08.30.458225.
4
A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.一种糖基化 RBD 蛋白诱导针对奥密克戎和其他变体的增强型中和抗体,提高对 SARS-CoV-2 感染的保护作用。
J Virol. 2022 Sep 14;96(17):e0011822. doi: 10.1128/jvi.00118-22. Epub 2022 Aug 16.
5
A Bispecific Antibody Targeting RBD and S2 Potently Neutralizes SARS-CoV-2 Omicron and Other Variants of Concern.一种靶向 RBD 和 S2 的双特异性抗体能有效中和 SARS-CoV-2 奥密克戎及其他关注变异株。
J Virol. 2022 Aug 24;96(16):e0077522. doi: 10.1128/jvi.00775-22. Epub 2022 Aug 2.
6
Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants.全面绘制 SARS-CoV-2 RBD 特异性中和抗体的结合热点,用于跟踪免疫逃逸变异株。
Genome Med. 2021 Oct 14;13(1):164. doi: 10.1186/s13073-021-00985-w.
7
In Silico Genome Analysis Reveals the Evolution and Potential Impact of SARS-CoV-2 Omicron Structural Changes on Host Immune Evasion and Antiviral Therapeutics.基于计算机的全基因组分析揭示了 SARS-CoV-2 奥密克戎结构变化对宿主免疫逃逸和抗病毒治疗的影响及其进化。
Viruses. 2022 Nov 6;14(11):2461. doi: 10.3390/v14112461.
8
Omicron: A Heavily Mutated SARS-CoV-2 Variant Exhibits Stronger Binding to ACE2 and Potently Escapes Approved COVID-19 Therapeutic Antibodies.奥密克戎:一种高度突变的 SARS-CoV-2 变体,表现出对 ACE2 更强的结合能力,并能有效逃避已批准的 COVID-19 治疗性抗体。
Front Immunol. 2022 Jan 24;12:830527. doi: 10.3389/fimmu.2021.830527. eCollection 2021.
9
The landscape of antibody binding affinity in SARS-CoV-2 Omicron BA.1 evolution.SARS-CoV-2 奥密克戎 BA.1 进化过程中抗体结合亲和力的全景。
Elife. 2023 Feb 21;12:e83442. doi: 10.7554/eLife.83442.
10
Analysis of a SARS-CoV-2 convalescent cohort identified a common strategy for escape of vaccine-induced anti-RBD antibodies by Beta and Omicron variants.对 SARS-CoV-2 恢复期患者队列的分析表明,β和奥密克戎变异株通过共同策略逃避了疫苗诱导的针对 RBD 的抗体。
EBioMedicine. 2022 Jun;80:104025. doi: 10.1016/j.ebiom.2022.104025. Epub 2022 May 6.

引用本文的文献

1
Genomic architecture and evolutionary relationship of BA.2.75: A Centaurus subvariant of Omicron SARS-CoV-2.基因组结构和进化关系的 BA.2.75:奥密克戎 SARS-CoV-2 的半人马座亚变种。
PLoS One. 2023 May 24;18(5):e0281159. doi: 10.1371/journal.pone.0281159. eCollection 2023.

本文引用的文献

1
Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant.德尔塔刺突 P681R 突变增强了 SARS-CoV-2 对阿尔法变体的适应能力。
Cell Rep. 2022 May 17;39(7):110829. doi: 10.1016/j.celrep.2022.110829. Epub 2022 Apr 29.
2
Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa.南非出现奥密克戎后,SARS-CoV-2 再感染的风险增加。
Science. 2022 May 6;376(6593):eabn4947. doi: 10.1126/science.abn4947.
3
The N501Y spike substitution enhances SARS-CoV-2 infection and transmission.N501Y 刺突突变增强了 SARS-CoV-2 的感染和传播。
Nature. 2022 Feb;602(7896):294-299. doi: 10.1038/s41586-021-04245-0. Epub 2021 Nov 24.
4
Cross-neutralization of SARS-CoV-2 Kappa and Delta variants by inactivated vaccine-elicited serum and monoclonal antibodies.灭活疫苗诱导的血清和单克隆抗体对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)kappa和Delta变异株的交叉中和作用。
Cell Discov. 2021 Nov 23;7(1):112. doi: 10.1038/s41421-021-00347-1.
5
An Antigenic Space Framework for Understanding Antibody Escape of SARS-CoV-2 Variants.用于理解 SARS-CoV-2 变体抗体逃逸的抗原空间框架。
Viruses. 2021 Oct 6;13(10):2009. doi: 10.3390/v13102009.
6
Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study.定义由 SARS-CoV-2 抗体靶向的变异耐药表位:全球联盟研究。
Science. 2021 Oct 22;374(6566):472-478. doi: 10.1126/science.abh2315. Epub 2021 Sep 23.
7
High genetic barrier to SARS-CoV-2 polyclonal neutralizing antibody escape.SARS-CoV-2 多克隆中和抗体逃逸的高遗传屏障。
Nature. 2021 Dec;600(7889):512-516. doi: 10.1038/s41586-021-04005-0. Epub 2021 Sep 20.
8
COVID-19 vaccines: Keeping pace with SARS-CoV-2 variants.COVID-19 疫苗:紧跟 SARS-CoV-2 变异株。
Cell. 2021 Sep 30;184(20):5077-5081. doi: 10.1016/j.cell.2021.09.010. Epub 2021 Sep 17.
9
SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution.SARS-CoV-2 变体预测和抗病毒药物设计可通过 RBD 体外进化实现。
Nat Microbiol. 2021 Sep;6(9):1188-1198. doi: 10.1038/s41564-021-00954-4. Epub 2021 Aug 16.
10
Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations.SARS-CoV-2 中和抗体的亲和力成熟赋予了对病毒逃逸突变的效力、广度和恢复能力。
Immunity. 2021 Aug 10;54(8):1853-1868.e7. doi: 10.1016/j.immuni.2021.07.008. Epub 2021 Jul 30.